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Abstract
Background: In eukaryotes, tRNA trafficking between the nucleus and cytoplasm is a complex process connected
with cell cycle regulation. Such trafficking is therefore of fundamental importance in cell biology, and disruption of
this process has grave consequences for cell viability and survival. To cope with harsh habitats, Artemia has evolved
a special reproductive mode to release encysted embryos in which cell division can be maintained in a dormancy
state for a long period.
Results: Using Artemia as a peculiar model of the cell cycle, an La-related protein from Artemia, named Ar-Larp,
was found to bind to tRNA and accumulate in the nucleus, leading to cell cycle arrest and controlling the onset of
diapause formation in Artemia. Furthermore, exogenous gene expression of Ar-Larp could induce cell cycle arrest in
cancer cells and suppress tumor growth in a xenograft mouse model, similar to the results obtained in diapause
embryos of Artemia. Our study of tRNA trafficking indicated that Ar-Larp controls cell cycle arrest by binding to
tRNAs and influencing their retrograde movement from the cytoplasm to the nucleus, which is connected to
pathways involved in cell cycle checkpoints.
Conclusions: These findings in Artemia offer new insights into the mechanism underlying cell cycle arrest
regulation, as well as providing a potentially novel approach to study tRNA retrograde movement from the
cytoplasm to the nucleus.
Keywords: Artemia, Cell cycle arrest, Diapause embryo, La-related protein, Nuclear retrograde of tRNA
Background
Regulation of the cell cycle involves processes crucial to
survival, including the detection and repair of genetic
damage and the prevention of uncontrolled cell division.
This subject has attracted much attention and has enor-
mous practical implications for combating cancer. The
cell cycle has several well-controlled phases. Progression
into each phase is tightly regulated by checkpoints and
inhibitors [1, 2]. The checkpoint allows the cell to repair
DNA damage before entering mitosis, and studies of this
process may lead to chemotherapies with increased cyto-
toxicity. Two families, Cip/Kip and INK4a/ARF, prevent
progression of the cell cycle. The Cip/Kip family in-
cludes p21, p27, and p57, which halt the cell cycle in G1
phase by binding to and inactivating cyclin-CDK com-
plexes [3]. The INK4a/ARF family includes p16INK4a,
which binds to CDK4 and arrests the cell cycle in G1
phase, and p14Arf in humans, which prevents p53 deg-
radation [1]. Each of these proteins acts through check-
point signaling pathways that lead to cell cycle arrest [4].
In response to environmental stresses, such as starvation
or treatment with thymidine or aphidicolin, cell cycle
progress is halted in G1 phase by the control of multiple
molecular pathways, rather than a single pathway [5].
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In eukaryotes, tRNA trafficking between the nucleus
and the cytoplasm is a complex process that often re-
sponds to environmental stress, thereby connecting tran-
scription in the nucleus to translation in the cytoplasm
[6]. This trafficking is of fundamental importance to cell
biology, and disruption of this process has grave conse-
quences for cell viability and survival. In response to
genotoxic stress, regulation of tRNA trafficking consti-
tutes an integral physiological adaptation to DNA dam-
age at the cell cycle checkpoint. For example, in the
yeast Saccharomyces cerevisiae, un-spliced tRNA rapidly
accumulates in the nuclei, and cell cycle progression is
delayed at the G1 to S phase transition [7, 8]. In contrast
to previous findings that showed that the transport of
tRNA is unidirectional from the nucleus to the cyto-
plasm, recent studies have revealed that cytoplasmic
tRNAs move retrogradely toward the nucleus and accu-
mulate in response to nutrient deprivation [9–12].
Retrograde tRNA nuclear import might also serve to
proofread tRNAs after splicing in order to separate im-
properly spliced tRNAs from the translation machinery
[13]. The regulation of tRNA trafficking is dependent on
the subcellular distribution of the elongation factor
Tef1/2 (the yeast ortholog of eEF1α). The function of
Tef1/2 is required for efficient tRNA nuclear export [14]
and is dependent on Msn5 and Mtr10, as is the tRNA
retrograde transport pathway [15].
La proteins are confined to the nucleus and the
complete evolutionary in eukaryotic cells. Structural ana-
lysis of these proteins resulted in their classification into
five families, namely the genuine La homologs and four
Larp families: Larp1, 4, 6, and 7 [16, 17]. La proteins
contain two RNA-binding motifs (RRMs) and an La
motif, and have important functions in RNA metabol-
ism. These proteins interact with an extensive variety of
cellular RNAs, and exhibit activities to promote the me-
tabolism of nascent pol III transcripts by binding to their
common UUU-3’OH-containing ends and to modulate
the translation of certain mRNAs involving an unknown
binding mechanism [18].
The Artemia model studied here is found in severely
hypersaline environments. Under certain conditions, ma-
ture females produce and release encysted gastrula em-
bryos (also called cysts) that enter diapause, a state of
obligate dormancy. Different environmental cues lead to
uninterrupted (direct) embryonic development, resulting
in the release of swimming nauplius larvae [19]. A fea-
ture of diapause embryos that is central to the present
study is the complete absence of cell division and DNA
synthesis during embryonic diapause [20, 21]. Diapause
can be terminated by certain environmental conditions,
leading to activated post-diapause embryos [19, 21]. Re-
markably, these activated encysted embryos develop
without any DNA synthesis or cell division [22], and
eventually hatch as nauplius larvae, at which point DNA
synthesis and cell division resume [21, 23]. The Artemia
model depicts adaptation as a complex response to crit-
ical life conditions, integrating and refining past and
present experiences at all levels of organization [24].
To elucidate the molecular mechanism underlying cell
cycle arrest and its link to the regulation of tRNA
nucleocytoplasmic trafficking, Artemia diapause was
used as a cell cycle arrest model. In this study, an RNA-
binding and La-related protein, named Ar-Larp, was
found to accumulate in the nucleus in response to cell
cycle arrest, which resulted in the formation of Artemia
diapause by binding to tRNAs. The mechanisms under-
lying the regulation of cell cycle arrest by Ar-Larp were
elucidated in cancer cells using exogenous Ar-Larp gene
transfection and expression. Cell cycle arrest induced by
tRNA retrograde movement from the cytoplasm to the
nucleus was then demonstrated in cancer cells. Our re-
sults indicated that tRNA trafficking regulates the mito-
genesis and proliferation of cells through cell cycle
checkpoints, a process that is mediated by multiple sig-
naling pathways including histone H3 acetylated at ly-
sine 56 (H3K56ac), extracellular signal-regulated kinase
(ERK), and Akt. Ar-Larp is thus an upstream signal of
tRNA trafficking that regulates cell cycle progression in
response to environmental stresses.
Results and discussion
Progress and characterization of cell cycle arrest during
Artemia diapause formation
As a survival strategy, Artemia possesses two independ-
ent reproductive pathways that allow adaptation to
widely fluctuating environments. Under unfavorable
conditions, mature females produce and release encysted
embryos that enter diapause, a state of obligate dor-
mancy (oviparous pathway; Fig. 1a). Alternatively, under
favorable conditions, they release swimming nauplius
larvae directly (ovoviviparous pathway; Fig. 1a). To de-
termine the cell division state in each developmental
stage, Western blotting was performed to analyze the ex-
pression of the mitosis markers CDK6, cyclin D3, phos-
phorylated Rb at Thr356, and phosphorylated histone
H3 at Ser10, all of which were strongly inhibited in the
diapause and post-diapause stages (Fig. 1b). The results
suggested that the cell cycle ceased during the diapause
and post-diapause stages compared with the pre-
diapause and larval stages, in which cell division was
widespread.
To distinguish the cell cycle phases of diapause and
post-diapause embryos, which are characterized as non-
dividing cells, their DNA content was analyzed by flow
cytometry. Analysis of the cell population distribution in
diapause embryos revealed that more than 90 % of cells
were in G0/G1 phase, whereas in post-diapause
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embryos, more than 85 % of cells were in G2/M phase,
with very few cells in G0/G1 phase (Fig. 1c). These re-
sults were validated by the incorporation of 5-bromo-2’-
deoxyuridine (BrdU). The lack of any BrdU signal in
diapause embryos revealed that the cell cycle had been
arrested before S phase; in contrast, the signal could be
detected in post-diapause embryos that had progressed
to G2/M phase during activation (Fig. 1d). Furthermore,
the proliferation markers Ki67 and proliferating cell nu-
clear antigen were not detected in cells of diapause em-
bryos, but were detected in cells of pre-diapause and
post-diapause embryos and nauplii (Fig. 1e).
Characterization of a La-related protein from Artemia
during diapause formation
During Artemia diapause formation, a gene encoding an
RNA-binding protein is expressed specifically in oocytes
in the Artemia ovisac [25]. In the current study, the ex-
pression of this gene, named Ar-Larp, was characterized
by real-time PCR. This showed that the gene was
expressed strongly in diapause-destined Artemia, but at
a very low level in the directly developing pathway. In
the former, Ar-Larp gene expression levels increased
during diapause formation, reaching a maximum level in
the encysted gastrula. Ar-Larp expression then de-
creased in post-diapause gastrula and disappeared in
hatched nauplii (Fig. 2a).
The Ar-Larp cDNA was cloned and sequenced to reveal
a 1215 bp region with a single open reading frame encoding
a 404 amino acid (aa) protein (Additional file 1: Figure S1).
The molecular mass and isoelectric point of the Ar-Larp
protein were calculated as 46.81 kDa and 8.60, respectively.
According to the structure analysis, Ar-Larp contains an La
motif (aa position 9–88) and two RNA recognition motifs,
RRM1 (aa position 101–170) and RRM2 (aa position 282–
365), which are found in La and Larp proteins of many
other species, ranging from trypanosomes to humans
(Additional file 1: Figure S2). However, comparing the
Fig. 1 Progression and characterization of cell cycle arrest during Artemia diapause embryo formation and termination. a Developmental stages
of Artemia during diapause formation (oviparous pathway) and direct development (ovoviviparous pathway). 1, Pre-diapause (early embryos); 2,
diapause; 3, post-diapause; 4, nauplii; 1', early embryos; 4', nauplii. Scale bar = 1 mm. b Expression of the mitosis markers CDK6, cyclin D3,
phosphorylated Rb (Thr356), and phosphorylated histone H3 (Ser10) at various stages of development. The lane numbers correspond to the
developmental stages shown in (a). Histone H3 (H3) and α-tubulin were used as the loading controls for the nucleus and cytoplasm, respectively.
c Analysis of the cell cycle phase during various stages of development. Flow cytometry analysis was performed with a fixed cell suspension
stained with PE at each stage. The right panel shows the DNA content of cells in each stage during diapause formation. d 5-bromo-2’-deoxyuri-
dine (BrdU) incorporation assay and e immunofluorescence of the proliferation markers Ki67 and proliferating cell nuclear antigen at each stage
of Artemia during diapause formation. Scale bar = 500 μm
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sequence with other proteins in the DDBJ/EMBL/GenBank
database revealed that Ar-Larp has very low sequence iden-
tity to other known proteins (less than 20 %).
Using polyclonal antibodies specific to Ar-Larp, a band
of about 47 kDa was identified in several stages of
diapause-destined embryos, including oocytes and early,
diapause, and post-diapause embryos, but not in hatched
nauplii. In contrast, Ar-Larp was not detected in oo-
cytes, embryos, or released nauplii of directly developing
Artemia (Fig. 2b). In addition, Ar-Larp accumulated in
the nuclei of diapause embryos, its level was decreased
in the nuclei of post-diapause embryos, and it was un-
detectable in hatched nauplii (Fig. 2c). These results in-
dicated that Ar-Larp is a diapause-specific protein.
Furthermore, the nuclear accumulation and retention of
Ar-Larp in diapause cysts of Artemia may have more
important functions in cell cycle arrest during diapause
embryo formation.
Ar-Larp is required for diapause formation in Artemia and
exhibits tRNA-binding activity
RNA interference (RNAi) was used to knockdown
Ar-Larp gene expression to elucidate the function of Ar-
Larp during the regulation of cell cycle arrest at the onset
of Artemia diapause. Just before ovarian development, a
double-stranded RNA (dsRNA), designed from the Ar-
Larp cDNA sequence, was injected into the body cavity of
adult oviparous Artemia. One day after the formation of
diapause embryos (about 2 weeks post-injection), Ar-Larp
mRNA levels decreased in proportion to increasing doses
of the dsRNA (Fig. 3a). After injection of 800 ng of
dsRNA, the Ar-Larp mRNA level was less than 15 % of
that in the control, and Ar-Larp protein expression
remained undetectable by immunoblot analysis. In
contrast to the control, neither the cell cycle nor embryo-
genesis were arrested in gene-knockdown embryonic cells.
This prevented diapause formation and produced pseudo-
diapause, in which the embryos continued to develop and
hatch into nauplii (Fig. 3b). In gene-knockdown embryos,
the restriction of cyclin D3 and CDK6 expression and the
block in phosphorylation of Rb (at Thr356 and Ser807/
811) and histone H3 (at Ser10) were removed (Fig. 3c).
These results strongly suggested that the knockdown pre-
vented the formation of a complete diapause state, result-
ing in a pseudodiapause embryo in which the cell cycle
was not arrested, and the embryos continued to develop
and hatch into nauplii.
To understand Artemia diapause formation, previous
studies have focused on molecules associated with ex-
treme environmental tolerance. For example, the small
heat shock/α-crystallin protein p26, which acts as a mo-
lecular chaperone, is expressed in diapause cysts and is
transported into nuclei during periods of environmental
stress [26, 27]. In addition, a cyst-specific protein, artemin,
has high thermal stability and functions as an RNA
chaperone in the cytoplasm [28, 29]. In the current study,
knockdown of the Ar-Larp gene prevented the formation
of a complete diapause state and inhibited expression of
p26 and artemin (Fig. 3c).
Based on our structural analysis, Ar-Larp contains a
La motif and two RRM motifs, suggesting that the pro-
tein is capable of recognizing and binding to RNAs.
Here, we examined the interaction between recombinant
Ar-Larp (GST-Ar-Larp) and tRNAs using an elec-
trophoretic mobility shift assay (EMSA). The results
showed that GST-Ar-Larp could form a complex with
tRNA in vitro, and the complex was identified as a
super-shifted band when an anti-Ar-Larp antibody was
Fig. 2 Ar-Larp gene expression in each developmental stage of Artemia in the oviparous and ovoviviparous pathways. a Real-time quantitative PCR
analysis of Ar-Larp expression during each developmental stage (indicated in Fig. 1a). Error bars represent the mean ± SD of three independent
experiments. b Western blot analysis of Ar-Larp during each developmental stage using α-tubulin as the loading control. c Subcellular location of
Ar-Larp. Western blot analysis of Ar-Larp in the cytoplasm and nucleus during each developmental stage of the oviparous pathway. Histone H3 (H3)
and α-tubulin served as the loading controls for the nuclear and cytoplasmic samples, respectively
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incubated together with Ar-Larp and tRNAs (Fig. 4a).
To clarify the binding specificity of Ar-Larp to tRNA,
several RNAs, including 5.8S rRNA, 5S rRNA, and
mRNAs, were used as competitors of the binding. The
result showed that none of these RNAs competed with
the binding of Ar-Larp to tRNAs (Fig. 4b). Furthermore,
the results of Northern blotting indicated that Ar-Larp
could efficiently bind to both pre-tRNA and mature
tRNA (Fig. 4c).
Both genetic and biochemical studies have revealed that
a major role of La is to protect the 3’ end of nascent small
RNAs from exonuclease digestion [30, 31]. Although less
is known about the roles played by the La protein binding
to mature tRNAs, there is a report demonstrating LARP7-
mature tRNA interaction in vivo [32]. It should also be
noted that Artemia oocytes are unusual cells, in that large
quantities of proteins and RNAs are stored in preparation
for early development. Thus, results obtained in Artemia
oocytes may differ from other kinds of cells.
Next, co-immunoprecipitation (co-IP) was performed
to investigate whether this interaction occurred in
Artemia. Ar-Larp-tRNA complexes were identified in dia-
pause embryos of Artemia and could be detected using sev-
eral tRNA probes (Fig. 4d). However, the Ar-Larp-mRNA
complex was not detected using probes specific for the
mRNAs of tubulin, p26, and artemin, which are transcribed
during diapause, indicating that Ar-Larp does not interact
with mRNAs in Artemia (data not shown). Based on these
results, we suggest that Ar-Larp controls cell cycle arrest in
diapause by interacting with tRNAs in the nucleus.
Ar-Larp localizes to the nucleus and induces cell cycle
arrest in cancer cells
To explore the function of Ar-Larp in the regulation of
cell cycle arrest in systems other than Artemia, green
fluorescent protein (GFP)-fused Ar-Larp was overex-
pressed in the human cancer cell lines HeLa (Fig. 5a)
and MKN45 (Fig. 5b). Similar to the results obtained
with the diapause embryos of Artemia, GFP-fused Ar-
Larp localized to the nuclei in both of these cell lines
(Fig. 5a,b). The results of the BrdU incorporation assay,
the PKH26 label-retaining assay, and the expression of
the proliferation marker Ki67 showed that, in contrast to
control cells, cells overexpressing Ar-Larp had no mi-
totic activity (Fig. 5a,b). Flow cytometry analysis showed
that most GFP-only transfected control cells progressed
through S phase to G2/M phase, while GFP-Ar-Larp-
transfected cells did not progress to G2/M phase and
underwent cell cycle arrest (Fig. 5c). This result was also
supported by a cell proliferation assay on soft agar, in
which Ar-Larp clearly inhibited cell division and colony
formation (Additional file 1: Figure S3). These results in-
dicate that Ar-Larp induces cell cycle arrest in HeLa and
MKN45 cells.
La-related proteins are conserved proteins with diver-
gent structures and functions that interact with an ex-
tensive variety of cellular RNAs. Different La families
may have evolved specialized activities in RNA metabol-
ism [18]. Aberrant nuclear trafficking of La protein leads
to the disordered processing of associated precursor
tRNAs [31]. Although Ar-Larp has a low sequence
Fig. 3 RNA interference (RNAi) of Ar-Larp in Artemia. a The expression levels of Ar-Larp mRNA were determined by real-time quantitative PCR
after RNAi treatments. Int, intact; Ctrl, control treatment with 800 ng of GFP double stranded RNA (dsRNA). The proteins in diapause cysts were
analyzed by Western blotting and tubulin was used as the loading control. b The phenotypes of RNAi-treated cysts injected with 800 ng of
Ar-Larp dsRNA. Observation by the anatomical microscopy. Scale bar = 500 μm. Embryos treated with GFP dsRNA remained in diapause, whereas
those treated with Ar-Larp dsRNA entered a pseudodiapause and developed into nauplii. c Western blot analysis of CDK6, cyclin D3, p26, Artemin,
phosphorylated Rb (Thr356 and Ser807/811), and phosphorylated histone H3 (Ser10) after RNAi of Ar-Larp. Histone H3 (H3) and α-tubulin were
used as the loading controls for the nucleus and cytoplasm, respectively
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identity to other known Larps, we found that it contains
an La motif and two RRMs that are conserved in the
Larp family (Additional file 1: Figure S4). To identify the
Ar-Larp motifs that are important for its nuclear
localization, its tRNA-binding, and its ability to regulate
cell cycle arrest, six Ar-Larp mutants with various motif
deletions were constructed and purified. The results of
the tRNA-binding activity of each mutant indicated that
both RRM1 and RRM2 participate in the tRNA-specific
binding activity of Ar-Larp (Additional file 1: Figure S5).
The La motif of Ar-Larp did not show tRNA-binding ac-
tivity, although it had typical secondary and tertiary
structures (Additional file 1: Figure S4). However, when
this motif was aligned with other known La proteins,
Phe residues at 23, 33, and 55 positions conserved in
β-sheet 1 and 2 of the La motif in the proteins were chan-
ged to Leu, Val, and Cys residues in Ar-Larp. These con-
served Phe residues are considered to be important for
RNA recognition and tRNA-binding of the La motif in
these proteins. Furthermore, the expression of the Ar-
Larp mutants in HeLa cells suggested that the linker be-
tween RRM1 and RRM2 is associated with the retention
of Ar-Larp in the nuclei of these cells (Additional file 1:
Figure S6). Based on these results, six additional Ar-Larp
mutants with various motif deletions were constructed
and overexpressed in HeLa cells. BrdU incorporation was
analyzed to detect the proliferation status. Mutants that
had tRNA-binding activity without being retained in
Fig. 4 Analysis of the tRNA-binding activity of Ar-Larp. a Electrophoretic mobility shift assay (EMSA) analysis of the affinity between Ar-Larp and
tRNAs. All tRNAs (25 μg per lane) were labeled with digoxigenin (DIG) using the DIG Oligonucleotide 3'-End Labeling Kit. Lanes 2–5 contain
increasing amounts (0–1 μg) of GST-fused Ar-Larp. Ar-Larp-tRNA complexes were detected by Northern blotting (1 μg of GST was used as a
control in lane 1). In lanes 7–8, excess tRNAs (250 and 500 μg, respectively) were added to the reaction system, which prohibited the binding
of Ar-Larp to labeled tRNAs. In lanes 9–10, an anti-Ar-Larp antibody (0.5 and 2 μg, respectively) was added to the reaction system, and the
super-shifted band of the Ar-Larp-anti-tRNA antibody complex was detected. b Competition EMSA analysis of the affinity between Ar-Larp and
tRNAs and other RNAs. All tRNAs (25 μg per lane) were labeled with DIG using the DIG Oligonucleotide 3'-End Labeling Kit. Lanes 1–4 contain
increasing amounts (0–1 μg) of GST-fused Ar-Larp. Ar-Larp-tRNA complexes were detected by Northern blotting. In lanes 5–8, excess RNAs (tRNA,
5.8 s rRNA, 5 s rRNA, and mRNAs, 500 μg each) were added to the reaction system as the competitors to prohibit the binding of Ar-Larp to
labeled tRNAs. c EMSA analysis of the affinity between Ar-Larp and pre-tRNA and mature tRNA. Unlabeled tRNAs (25 μg per lane) were incubated with
GST-Ar-Larp (0–1 μg). Ar-Larp-tRNA complexes were detected using probes specific to pre-tRNA (tRNALeu, c-left panel) and mature tRNA (tRNALeu,
c-right panel) (1 μg of GST was used as a control in lane 1). d Detection of Ar-Larp-tRNA complexes by co-IP using an anti-Ar-Larp antibody and probes
specific to tRNAs. Northern blot analysis of tRNAs from the pellets (co-immunoprecipitation) or total extract fractions (Input) of Artemia
cells at each developmental stage (indicated in Fig. 1a, isotype antibody was used as a control)
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nuclei (Additional file 1: Figure S7a,b) or were retained in
nuclei without tRNA-binding activity (Additional file 1:
Figure S7e) could not induce cell quiescence. Only a com-
bination of the nuclear retention (linker) and tRNA-
binding (RRM1 and/or RRM2) regions could induce cell
quiescence (Additional file 1: Figure S7c,d,f).
To investigate whether Ar-Larp could induce cell quies-
cence in a mouse tumor model, an Ar-Larp adenovirus
(Ad-Ar-Larp) was constructed and injected into HeLa and
HT1080 human tumor xenograft model mice. Western
blotting revealed the presence of Ar-Larp in tumor
specimens, indicating that the protein was successfully
expressed from the adenovirus construct in vivo (Fig. 6a
insertion). Ar-Larp suppressed the growth of both HeLa
and HT1080 tumors, representing 56 % and 55 %, respect-
ively, of tumor formation in control mice (Fig. 6a).
Importantly, BrdU labeling and detection revealed that all
Ar-Larp-expressing cells in both HeLa and HT1080
tumors showed no mitotic activity compared with their
controls (Fig. 6b). Further analysis indicated that expres-
sion of cyclin D3, CDK4/6, and phosphorylated Rb was
strongly inhibited in HeLa tumors expressing Ar-Larp in
contrast to the controls (Fig. 6c). Based on these results,
we concluded that Ar-Larp is capable of inducing cell
cycle arrest in tumors as well as in Artemia embryos.
Ar-Larp controls cell cycle arrest by retrograde transport
of tRNAs to the nucleus and its signaling pathways
To address the function of Ar-Larp in cell cycle regula-
tion, GFP-fused Ar-Larp was transfected into HeLa cells
and tRNA trafficking was analyzed. Fluorescence in situ
hybridization (FISH) using tRNA-specific probes was
used to examine the distribution of tRNAs. The results
indicated that tRNAs accumulated significantly in the
Fig. 5 Ar-Larp overexpression results in cell cycle arrest in HeLa and MKN45 cells. Transient transfection of Ar-Larp in (a) HeLa and (b) MKN45 cells.
Overexpressed green fluorescent protein (GFP) alone, green in control cells; overexpressed GFP-Ar-Larp, green in Ar-Larp-transfected cells. Mitosis
was evaluated using the BrdU incorporation assay, the PKH26 label-retaining assay, and immunohistochemistry of Ki67. Cells overexpressing
Ar-Larp (white arrows) lacked mitotic activity and remained in cell cycle arrest. c Flow cytometry analysis of the DNA content of HeLa cells using
GFP (control) and GFP-Ar-Larp gene transfection. The bar graph shows the transition ratios from G1/S phase to G2/M phase in HeLa cells at 18
and 24 h after GFP-Ar-Larp gene transfection
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nuclei of Ar-Larp-transfected HeLa cells compared to
the controls (Fig. 7a). In addition, a co-IP assay was per-
formed using an anti-Ar-Larp antibody to identify the
tRNAs that accumulated in the nucleus. Immunoprecipi-
tates were detected in cells transfected with the GFP-
fused Ar-Larp gene using several tRNA probes (Fig. 7b).
The results suggested that Ar-Larp induces cell cycle ar-
rest by regulating tRNA trafficking.
To address whether the accumulation of tRNAs in the
nucleus was due to the suppression of trafficking to the
cytoplasm or retrograde transport from the cytoplasm,
actinomycin D (ActD, 5 μM) was used to block de novo
tRNA synthesis. In complete medium, tRNA could not
be detected in the nuclei of control cells treated with
ActD; however, tRNA accumulation in the nuclei was
observed in Ar-Larp-overexpressing cells treated with
ActD (Fig. 7c). During the nuclear transport of Ar-Larp
(from 18 to 36 h after expression), the accumulation and
retention of tRNAs was increased. The results indicated
that tRNAs accumulated in the nuclei of Ar-Larp-
overexpressing cells by moving retrogradely from the
cytoplasm through the nuclear transport of Ar-Larp.
Although the regulation of post-transcriptional gene
expression by tRNA nuclear accumulation remains an
unproven possibility, evidence indicates that retrograde
tRNA nuclear accumulation occurs in response to envir-
onmental stress. Previous studies reported that tRNA
moves retrogradely from the cytoplasm to the nucleus in
rat hepatoma and S. cerevisiae cells in response to aa
deprivation [9, 10, 33, 34]. Thus, retrograde tRNA nu-
clear import may serve a regulatory role, separating
tRNA from the translation machinery and resulting in
the down-regulation of translation. However, the mech-
anism underlying tRNA nuclear import is unclear. In
this report, our results indicate that Ar-Larp can func-
tion directly in retrograde tRNA nuclear import.
Based on the structural analysis, Ar-Larp from Artemia
contains a La motif and two RRMs that are also found in
La protein and LARP7. However, we found that Ar-Larp
shows only 18 % and 17 % sequence identities to human
La protein and LARP7, respectively (Additional file 1:
Figure S8). Furthermore, human La protein and LARP7
did not show the activity of regulation in cell cycle arrest
when they were overexpressed in HeLa cell line
(Additional file 1: Figure S9). The previous report indi-
cated that LARP7 inhibits breast cancer progression by
binding to P-TEFb and 7SKsnRNA [35]. In this study, the
complex of Ar-Larp binding with P-TEFb and 7SKsnRNA
was not observed in Ar-Larp overexpressing HeLa cells by
co-IP analysis and in vitro by EMSA analysis (Additional
file 1: Figure S10). In addition, we did not find any
homologue of Ar-Larp in HeLa cell by using anti-Ar-Larp
antibody (Additional file 1: Figure S11). The results
indicated that the structure and function of Ar-Larp is
different to those of human La protein or LARP7 and the
structure of molecule retrograded tRNA from cytoplasm
Fig. 6 Ar-Larp inhibits mitosis of HeLa and HT1080 cells in mouse xenograft tumor models. a Female BALB/c nude mice were intratumorally treated
with Ad-Ar-Larp or Ad-control after the formation of HeLa or HT1080 tumors. Tumor volumes and images are shown. The error bars represent the
mean ± SD for five animals. Ar-Larp expression in the tumors was detected by Western blotting (insert). b Mitotic activity of cells in HeLa and HT1080
tumors examined using the BrdU incorporation assay after treatment with Ad-Ar-Larp or Ad-control. Blue, nuclei counterstained with DAPI. Green,
Ar-Larp detected with a FITC-conjugated anti-Ar-Larp antibody. Red, incorporated BrdU detected with a rhodamine-conjugated anti-digoxigenin
antibody. There is no mitotic activity in the green cells in the merged fields. Scale bar = 50 μm. c Expression of Ar-Larp and mitosis markers including
CDK6, cyclin D3, and phosphorylated Rb (Thr356, Ser780, and Ser807/811). Tubulin was used as a loading control
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to nucleus leading to cell cycle arrest in human maybe dif-
ferent with that of Ar-Larp.
Furthermore, we compared the effect of Ar-Larp and
protein synthesis inhibitors, such as puromycin, cyclo-
heximide, and fusidic acid, which block protein synthesis
in the elongation or translocation steps. Unlike cell cycle
arrest induced by Ar-Larp, tRNA retrograde movement
from the cytoplasm to the nucleus was not observed in
MKN45 cells treated with these inhibitors (Additional
file 1: Figure S12).
The tRNA distribution in cells of each stage during
diapause formation and in pseudodiapause cysts
induced by Ar-Larp RNAi in Artemia was identified
by FISH analysis using a tRNALeu probe (Fig. 7d).
The result showed that the distribution of tRNAs
coincided with the expression and distribution of Ar-
Larp. In diapause cyst cells, tRNAs accumulated in
nuclei; however, in pseudo diapause cyst cells induced
by Ar-Larp RNAi (as shown in Fig. 3b), the accumu-
lation of tRNAs in nuclei disappeared simultaneously
(Fig. 7d). Based on the results obtained in this study,
we propose that Ar-Larp regulates cell quiescence
through its involvement in the retrograde nuclear ac-
cumulation of cytoplasmic tRNAs.
Fig. 7 Ar-Larp retrogradely transports tRNAs from the cytoplasm to the nucleus, resulting in cell cycle arrest. a The tRNA distribution in HeLa
overexpressing GFP-Ar-Larp (white arrows indicate typical cells) or GFP alone. tRNAs were detected by FISH using oligonucleotide probes
complementary to tRNA sequences. Green, GFP-fused Ar-Larp and GFP alone. Red, tRNAs detected with a rhodamine-conjugated anti-digoxigenin
(anti-DIG) antibody. Blue, nuclei counterstained with DAPI. Scale bar = 50 μm. b Detection of Ar-Larp-tRNA complexes by co-immunoprecipitation
using an anti-Ar-Larp antibody and probes specific to the tRNAs. Northern blot analysis of tRNAs from the pellets (co-IP) or total extract fractions
(Input) of HeLa cells overexpressing GFP-Ar-Larp. Lane 1, HeLa cells overexpressing GFP-Ar-Larp; lane 2, control cells overexpressing GFP alone.
c Analysis of the retrograde transport of tRNA from the cytoplasm to the nuclei in Ar-Larp-overexpressing HeLa cells. HeLa cells were treated with
ActD (5 μM) to block tRNA synthesis for 2 h after Ar-Larp was expressed for 8 h. The nuclear and cytoplasmic distributions of tRNA in HeLa cells
were then detected by FISH using oligonucleotide probes (tRNALeu) complementary to the tRNA sequences at 18, 24, and 36 h after Ar-Larp
expression (white arrow indicates typical cells). Cells expressing GFP alone and two Ar-Larp mutants were used as controls. Mutant 1 lacked the
domain between RRM1 and RRM2, and therefore was not retained in the nucleus. Mutant 2 could accumulate and be retained in the nucleus,
but lacked the RNA-binding domain. Green, GFP-fused Ar-Larp and GFP alone. Red, tRNAs detected with a rhodamine-conjugated anti-DIG
antibody. Blue, nuclei counterstained with DAPI. Scale bar = 50 μm. d The distribution of tRNAs in cells at each stage during diapause formation
(the stages are indicated in Fig. 1a and in pseudodiapause cysts induced by Ar-Larp RNA interference. Dashed line circles indicate cells in each
stage and pseudodiapause cysts. Scale bar = 50 μm
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In our previous studies, we found that mitogen-
activated protein kinase-ERK-ribosomal S6 kinase 1 is
inhibited and H3K56ac accumulates in diapause em-
bryos [23, 36]. To clarify the signaling pathways linking
tRNA trafficking to the cell cycle checkpoint, the path-
ways concerned were analyzed by Western blotting. Of
the various processes and pathways involved, the level of
H3K56ac remained high, while the phosphorylation of
ERK1/2 and Akt was strongly inhibited. In addition, the
activation of FoxO3a was also inhibited in HeLa cells
after Ar-Larp gene transfection (Additional file 1: Figure
S13). However, Ar-Larp did not appear to have any ef-
fect on the molecules of the other tested signaling path-
ways (Additional file 1: Figure S14).
To confirm that Ar-Larp was responsible for activating
certain signaling pathways in Artemia, RNAi was
performed as described above. After knockdown of the
Ar-Larp gene, the level of H3K56ac was reduced and
phosphorylation of ERK1/2 and Akt was increased
(Additional file 1: Figure S15). Based on these findings,
we propose the molecular mechanism underlying Ar-
Larp-induced cell cycle arrest, as identified in this study.
Ar-Larp retrogradely transports tRNAs to the nucleus,
followed by the up-regulation of H3K56ac, and the
down-regulation of ERK1/2 and Akt phosphorylation
and inhibition of FoxO3a activation. Consequently, the
cyclin D3/CDK6 complex is inactivated, while Rb is
maintained in an active state to perform its function as a
tumor suppressor by inhibiting cell cycle progression.
Conclusions
The regulation of the cell cycle involves processes that
are crucial to survival, including the detection and repair
of genetic damage and the prevention of uncontrolled
cell division. Encysted gastrula in diapause released from
Artemia provides an excellent model system for studying
cell biology and the biochemical adaptation to extreme
environments. In this study, we used Artemia as a pecu-
liar model for cell cycle studies, and describe in detail
how the Artemia RNA-binding protein Ar-Larp controls
the onset of Artemia diapause, induces cell cycle arrest
at G1/S phase in human cancer cells, and suppresses
tumor growth in a xenograft mouse model. From
Artemia, we have learned considerably about how cysts
protect the embryos from extremely harsh environ-
ments, utilizing the capacity to maintain the embryos in
a state of cell cycle arrest for long periods of time. Un-
like protein inhibitors, Ar-Larp controls tRNA nucleocy-
toplasmic trafficking, transducing the signal to the cell
cycle checkpoints, including H3K56ac, ERK, and Akt,
which suppresses cell division. In this sense, Ar-Larp is
an extraordinary protein and will be extremely useful in
providing further insights into the regulation of cell div-
ision. Based on the unique structure and biological
function of the Ar-Larp molecule, Ar-Larp and its re-
lated processes should help to provide novel approaches
to non-specific gene therapies for cancer treatment.
Methods
Animals and ethics statement
Diapause-destined Artemia (Artemia parthenogenetica)
were raised in 8 % (w/v) artificial seawater (Blue Starfish)
at 25 °C on a 4L:20D cycle, while the directly developing
Artemia were reared in 4 % (w/v) artificial seawater on a
16L:8D cycle. Chlorella powder (Fuqing King Dnarmsa
Spirulina Co., Ltd.) was supplied as brine shrimp food.
BALB/c nude mice aged 6–8 weeks (Institution of
Animal Research, Shanghai, China) were used as xeno-
graft recipients for cancer cells. Animal experiments
were approved and performed in accordance with the
institutional guidelines for animal care of the animal
ethics committee of Zhejiang University.
Cell culture and transfection
HeLa, HT1080, and MKN45 cells (ATCC, VA, USA)
were cultured at 37 °C in 5 % CO2 in DMEM, RPMI-
1640, and EMEM (Genom, China), respectively, supple-
mented with 10 % fetal bovine serum (Gibco, MT, USA).
Cell transfections were performed with Lipofectamine
2000 (Invitrogen, CA, USA) as recommended by the
manufacturer.
Western blotting and antibodies
Ar-Larp protein with His-tag was expressed in Escherichia
coli BL21 (DE3) and purified using Ni-NTA Agarose
(Qiagen, Germany). The anti-Ar-Larp antibody was raised
in rabbits (HuaAn, China). For nuclear and cytoplasmic
fractions, the extracts were prepared using NPE Nuclear
and CPE Cytoplasmic Extraction Reagents (Bioteke,
China) following the manufacturer’s instructions. Proteins
were extracted from each tissue using protein loading buf-
fer (0.2 mM dithiothreitol, 4 % (w/v) sodium dodecyl sul-
fate (SDS), 0.2 % (w/v) bromophenol blue, and 20 % (v/v)
glycerol prepared in 0.1 mM Tris-HCl, pH 6.8). Fifty
micrograms of protein of each sample were separated on
12.5 % SDS-PAGE gels and transferred to PVDF mem-
branes (Millipore, MA, USA). The membranes were incu-
bated with antibodies overnight at 4 °C and detected using
the BM Chemiluminescence Western Blotting Kit (Roche,
Germany) following the manufacturer’s instructions.
Flow cytometry analysis
Fluorescence-activated cell sorting was performed as
previously described [23]. Data analysis was accom-
plished with Cell Quest™ software, version 3.1 (BD
Biosciences, NJ, USA). All data are presented as the
mean ± SD. All statistical analyses were performed using
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the two-tailed paired Student’s t-test. The differences
were considered statistically significant at P <0.01.
BrdU incorporation assay
In vivo BrdU labeling was performed according to the
manufacturer’s instructions (Sigma, MO, USA). Cells were
incubated with 12 mM BrdU (Sigma) for an additional
24 h after transfection. The incorporation of BrdU into
the genome was detected with a mouse anti-BrdU primary
antibody (Sigma) followed by a secondary goat anti-mouse
antibody conjugated to rhodamine (HuaAn). Wide-field
fluorescence microscopy was used to obtain images.
Quantitative real-time PCR
Total RNA was isolated using TRIzol reagent (Invitrogen).
cDNA was synthesized from 2 μg of total RNA using a
SuperScript™/First-Strand cDNA Synthesis kit (Invitrogen)
with Oligo(dT) primers. cDNA was diluted 10-fold and
combined with SYBR Green Supermix (TaKaRa, Japan)
for quantitative PCR. The relative abundance of mRNA
was normalized to that of α-tubulin. The results are
reported as the mean ± SD of three independent experi-
ments. Comparisons between groups for statistical signifi-
cance were performed with a two-tailed paired Student’s
t-test.
RNAi of the Ar-Larp gene
Recombinant plasmids expressing Ar-Larp dsRNAs were
constructed and the dsRNAs were induced, expressed,
and purified as described previously [23]. Ar-Larp
dsRNA (800 ng) was injected into the reproductive seg-
ment of Artemia using an UltraMicroPump II equipped
with a Micro4™ MicroSyringe Pump (World Precision
Instruments, FL, USA). Similarly, GFP dsRNA was
injected as the negative control.
EMSA
For the EMSA, yeast tRNAs (Ambion, USA) were first
labeled with the digoxigenin (DIG) Oligonucleotide 3'-
End Labeling Kit (Roche, USA) and then incubated with
various concentrations of a GST-Ar-Larp fusion protein
(0–1 μg) or GST alone (1 μg) in 20 μL of RNA-binding
buffer (Tris (pH7.5) 0.1 M, KCl 0.5 M, dithiothreitol
10 mM, with diisodecyl glutarate) at room temperature
for 30 min. The reaction mixtures were electrophoresed
on 12.5 % non-denaturing polyacrylamide gels in Tris/
Borate/EDTA buffer, and detected using the Northern
Blotting Kit (Roche, Germany) following the manufac-
turer’s instructions. For the super-shift assay, an anti-Ar-
Larp antibody (0.5–1 μg) was incubated simultaneously
in the EMSA system. For competition EMSA experi-
ments, several excess competitors (10-fold unlabeled
tRNA, 5.8S rRNA, 5S RNA, and mRNAs) were added to
the EMSA system.
Co-IP
Crude protein extracts were prepared in the presence of
proteinase inhibitors (Sangon, China) and the RiboLock™
Ribonuclease Inhibitor (MBI, CT, USA), and were incu-
bated with an anti-Ar-Larp antibody (HuaAn) at 4 °C
overnight, followed by the addition of Protein A Dyna-
beads (Invitrogen) for 3 h at 4 °C. The beads were washed
with extraction buffer twice, and tRNAs were purified
using TRIzol reagent (Invitrogen). RNA was loaded onto
8 % urea denaturing polyacrylamide gels prior to
hybridization with tRNA oligonucleotide probes at 39 °C.
Mouse xenograft model
A recombinant adenovirus expressing Ar-Larp (Ad-Ar-
Larp) was constructed and purified using the Adenovirus
Dual Expression Kit (TaKaRa) following the manufac-
turer’s instructions. Tumor-bearing BALB/c nude mice
were injected with Ad-Ar-Larp or a control adenovirus
(Ad-control) twice a week. Tumor volumes were deter-
mined by measuring tumors in two dimensions as de-
scribed previously [37]. Four weeks later, the mice were
injected with BrdU (50 mg/kg) and ten hours later, the
mice were sacrificed and the tumors were harvested and
paraffin-embedded. BrdU incorporation was detected as
described above.
FISH
tRNA FISH was performed as described previously [38].
To block de novo tRNA synthesis, cells were treated
with 5 μM ActD (Sigma) for 2 h and then cultured in
complete medium. Cells were fixed and incubated with
3’ end DIG-labeled tRNA oligonucleotide probes for
hybridization at 39 °C. A rhodamine-conjugated anti-DIG
Fab fragment (Roche, Germany) was used to determine
the tRNA abundance. The tRNA oligonucleotide probes
are listed in Additional file 2: Supplemental Materials
and Methods.
Availability of data and materials
Supporting information and additional methods can be
found in Additional files 1, 2, and 3.
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Additional file 1: Figure S1. Nucleotide sequence of Ar-Larp cDNA and
its deduced amino acid sequences. Figure S2. Sequence alignment of
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family. Figure S3. Proliferation of HeLa cells overexpressing Ar-Larp.
Figure S4. Structural predictions for the Ar-Larp. Figure S5. The affinity
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